Pathology

Dr. Öğr. Üyesi Fatih Mert Doğukan

Doctor and researcher Başakşehir Çam ve Sakura Şehir Hastanesi İstanbul
Pituitary NeoplasmsNeuroendocrine TumorsThyroid NeoplasmsSoft Tissue NeoplasmsLupus Erythematosus, Systemic
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Pituitary Neoplasms 4 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Neuroendocrine Tumors 4 publications
  • Thyroid Neoplasms 2 publications
  • Soft Tissue Neoplasms 2 publications
  • Lupus Erythematosus, Systemic 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPathologysaglik.gov.trFrom source
  • InstitutionBaşakşehir Çam ve Sakura Şehir Hastanesisaglik.gov.trFrom source
  • Area of workPituitary NeoplasmsExtracted from 4 publications · Model version —From source
  • Publications31 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0001-7825-8296ORCIDFrom source
  • Last synchronised5 November 2026 10:37https://camsakurasehir.saglik.gov.tr/TR-1501419/gorev-yapan-hekimlerimiz.html#fatih-mert-dogukansaglik.gov.tr

Scientific work

Publications on Pituitary Neoplasms

31 publications

  1. Risk of malignancy and necessity of completion thyroidectomy in patients with indeterminate thyroid nodules (Bethesda III and IV), more than expected in endemic region

    Updates in Surgery, 2026

    DOI 10.1007/s13304-026-02655-1 PMID 42053951 Open-access full textSource: OpenAlex

  2. Calcitonin Gene-Related Peptide Expression in Somatotroph Adenomas: Implications for Clinical Course and Treatment Outcomes

    Neuroendocrinology, 2026

    DOI 10.1159/000551012 PMID 41746852 Source: ORCID

  3. Lineage-specific steroidomic signatures in pituitary neuroendocrine tumors: pregnenolone enrichment in SF-1 lineage and associations with tumor behavior

    Endocrine Related Cancer, 2026

    DOI 10.1530/erc-26-0154 PMID 42333631 Source: OpenAlex

  4. Differentiating pituitary metastasis from hypophysitis: A two-center study using conventional MRI and clinical features

    Clinical Neurology and Neurosurgery, 2026

    DOI 10.1016/j.clineuro.2026.109662 PMID 42874350 Source: OpenAlex

  5. Symptomatic Foreign Body Forgotten in the Ulnar Artery for 4 Years

    Turkiye Klinikleri Journal of Case Reports, 2026

    DOI 10.5336/caserep.2025-111856 Open-access full textSource: OpenAlex

  6. Predictors of re-biopsy in percutaneous musculoskeletal tumor biopsies: A single-center retrospective cohort study

    Journal of Orthopaedic Surgery, 2026

    DOI 10.1177/10225536261439408 PMID 41937504 Open-access full textSource: ORCID

  7. Is it possible to rule out level II and level VB dissection in patients with metastatic papillary thyroid cancer?

    Frontiers in Endocrinology, 2025

    DOI 10.3389/fendo.2025.1520539 PMID 40862116 Open-access full textSource: OpenAlex

  8. Risk of Malignancy Rate and Necessity of Completion Thyroidectomy in Patients with Indeterminate Thyroid Nodules (Bethesda III and IV), More Than Expected in Endemic Region

    British journal of surgery, 2025

    DOI 10.1093/bjs/znaf096.030 Open-access full textSource: OpenAlex

  9. SAT-074 Comparative Evaluation Of CGRP Expression In Pituitary Adenomas: Could It Be Linked To Clinical Course And Treatment Response In Acromegaly?

    Journal of the Endocrine Society, 2025

    DOI 10.1210/jendso/bvaf149.1556 Open-access full textSource: OpenAlex

  10. 519 Distant Metastatic Sites from Follicular Cell-Derived Thyroid Carcinoma Show Differential Enrichment of Molecular Alterations: A Series of 156 Cases

    Laboratory Investigation, 2025

    DOI 10.1016/j.labinv.2024.102749 Open-access full textSource: OpenAlex

View all 31 publications